132 related articles for article (PubMed ID: 11812454)
1. Prognosis for placebo-treated eyes in VIP report 2.
Da Pozzo S; Parodi MB
Am J Ophthalmol; 2002 Feb; 133(2):294-6. PubMed ID: 11812454
[No Abstract] [Full Text] [Related]
2. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
3. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration.
Jonas JB
Am J Ophthalmol; 2002 Jun; 133(6):857; author reply 857-9. PubMed ID: 12036694
[No Abstract] [Full Text] [Related]
4. Treatment of juxtafoveal and extrafoveal choroidal neovascularization in the era of photodynamic therapy with verteporfin.
Jampol LM; Scott L
Am J Ophthalmol; 2002 Jul; 134(1):99-101. PubMed ID: 12095815
[No Abstract] [Full Text] [Related]
5. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.
Fine SL
Arch Ophthalmol; 1999 Oct; 117(10):1400-2. PubMed ID: 10532450
[No Abstract] [Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
Barbazetto I; Burdan A; Bressler NM; Bressler SB; Haynes L; Kapetanios AD; Lukas J; Olsen K; Potter M; Reaves A; Rosenfeld P; Schachat AP; Strong HA; Wenkstern A; ;
Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608
[TBL] [Abstract][Full Text] [Related]
7. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
Hariprasad SM; Shah GK
Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
9. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
Pieramici DJ; Bressler SB; Koester JM; Bressler NM
Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
Bressler NM
Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
[No Abstract] [Full Text] [Related]
11. Photodynamic therapy in adult-onset vitelliform macular dystrophy misdiagnosed as choroidal neovascularization.
Menchini U; Giacomelli G; Cappelli S; Giansanti F; Romani A; Virgili G
Arch Ophthalmol; 2002 Dec; 120(12):1761-3. PubMed ID: 12470159
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration.
Piermarocchi S; Lo Giudice G; Sartore M; Friede F; Segato T; Pilotto E; Midena E
Am J Ophthalmol; 2002 Apr; 133(4):572-5. PubMed ID: 11931801
[TBL] [Abstract][Full Text] [Related]
14. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Isola V; Pece A; Brancato R
Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
[No Abstract] [Full Text] [Related]
15. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
16. Are the submacular surgery trials still relevant in an era of photodynamic therapy?
Bressler NM; Hawkins BS; Sternberg P; McDonald HR
Ophthalmology; 2001 Mar; 108(3):435-6. PubMed ID: 11237895
[No Abstract] [Full Text] [Related]
17. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease.
Andrade RE; Farah ME; Costa RA
Am J Ophthalmol; 2003 Dec; 136(6):1179-81. PubMed ID: 14644242
[TBL] [Abstract][Full Text] [Related]
18. Retinal and choroidal alterations following photodynamic therapy.
Durlu YK
Adv Exp Med Biol; 2003; 533():115-22. PubMed ID: 15180255
[No Abstract] [Full Text] [Related]
19. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
20. Comment on 'Photodynamic therapy in practice'.
Styles C
Clin Exp Ophthalmol; 2004 Feb; 32(1):119-20. PubMed ID: 14746611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
